Nicorandil Nitrate is a potassium channel activator and nitric oxide donor primarily used in the clinical management of angina pectoris. By opening ATP-sensitive potassium channels in vascular smooth muscle… Read more
Nicorandil Nitrate is a potassium channel activator and nitric oxide donor primarily used in the clinical management of angina pectoris. By opening ATP-sensitive potassium channels in vascular smooth muscle cells, this compound promotes vasodilation, which improves blood flow and oxygen delivery to the heart while reducing cardiac workload. In pharmaceutical research and development, high-quality reference standards of this drug, alongside its related pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, are critical for rigorous analytical testing. These materials enable accurate impurity profiling, method validation, and consistent quality control throughout the drug manufacturing process. Laboratories rely on these specific standards to identify trace degradation products and quantify active pharmaceutical ingredients, ensuring compliance with safety and efficacy guidelines for cardiovascular treatments.